Fig. 3From: Serum anti-phospholipase A2 receptor (PLA2R) antibody detected at diagnosis as a predictor for clinical remission in patients with primary membranous nephropathy: a meta-analysisForest plot for the correlation between ‘low’ or ‘high’ sPLA2R-ab titer by ELISA and the rate of clinical remissionBack to article page